Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | FGFR2 | P21802 | 18/20 | 0.64 |
| ▸ | FGFR1 | P11362 | 4/20 | 0.64 |
| ▸ | FGFR4 | P22455 | 4/20 | 0.64 |
| ▸ | FGFR3 | P22607 | 3/20 | 0.64 |
| ▸ | KDR | P35968 | 6/20 | 0.63 |
| ▸ | BTK | Q06187 | 1/20 | 0.63 |
| ▸ | SRC | P12931 | 2/20 | 0.51 |
| ▸ | EGFR | P00533 | 1/20 | 0.51 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL25334219 | 1.00 | FGFR2 (0.64) | FGFR2FGFR1FGFR4FGFR3KDR | |
| SCHEMBL29063791 | 0.94 | FGFR2 (0.61) | FGFR2FGFR1FGFR4FGFR3KDR | |
| SCHEMBL15345450 | 0.91 | FGFR2 (0.77) | FGFR2FGFR1FGFR4FGFR3KDR | |
| SCHEMBL30291188 | 0.91 | FGFR2 (0.77) | FGFR2FGFR1FGFR4FGFR3KDR | |
| SCHEMBL15345452 | 0.91 | FGFR2 (0.77) | FGFR2FGFR1FGFR4FGFR3KDR | |
| SCHEMBL15345598 | 0.87 | FGFR2 (0.60) | FGFR2FGFR1FGFR4FGFR3KDR | |
| SCHEMBL15345597 | 0.87 | FGFR2 (0.60) | FGFR2FGFR1FGFR4FGFR3KDR | |
| SCHEMBL25334838 | 0.86 | FGFR2 (0.84) | FGFR2FGFR1FGFR4FGFR3KDR | |
| SCHEMBL30515832 | 0.86 | FGFR2 (0.84) | FGFR2FGFR1FGFR4FGFR3KDR | |
| SCHEMBL25334852 | 0.86 | FGFR2 (0.84) | FGFR2FGFR1FGFR4FGFR3KDR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-116514806-A | Biological inhibitor containing acrylketone, preparation method and application thereof | 上海翰森生物医药科技有限公司 | 2023-08-01 | — | — | CN | disclosed |